Previous 10 | Next 10 |
home / stock / epwcf / epwcf news
Multiple Research Studies Are In Official Application Stage For EPW Curesearch Sites Covering Numerous Protocols And Specialties VANCOUVER, BC / ACCESSWIRE / July 31, 2023 / EMPOWER CLINICS INC (CSE:EPW)(OTCQB:EPWCF) (" Empower " or the " Company ") a healthcare company with a developing res...
Toronto, Ontario--(Newsfile Corp. - Le 20 juin/June 2023) - Empower Clinics Inc. has announced a consolidation of its issued and outstanding common shares on the basis of one (1) post-consolidated common share for every five (5) pre-consolidated common shares. As a result, the outstanding shar...
2023-06-20 08:12:49 ET Empower Clinics ( OTC:EPWCF ) plans to consolidate its issued and outstanding common shares in the ratio of one post-consolidation share for every five pre-consolidation Shares, effective June 21, 2023, with a record date of June 22, 2023. The current 437,69...
VANCOUVER, BC / ACCESSWIRE / June 19, 2023 / EMPOWER CLINICS INC. ( CSE:EPW)(OTCQB:EPWCF) (" Empower " or the " Company ") today announces its plan to consolidate its issued and outstanding common shares (each, a " Share ") on the basis of one post-consolidation share for every five pre-consoli...
2023-06-06 14:01:24 ET Empower Clinics ( OTC:EPWCF ) has announced that it has entered into a LOI with Crescita Capital for a C$5M equity capital facility, that Empower will have 3 years to utilize to develop the business of the Co. The Commitment is intended to be used f...
VANCOUVER, BC / ACCESSWIRE / June 6, 2023 / EMPOWER CLINICS INC (CSE:EPW) (PINK:EPWCF) (" Empower " or the " Company ") an integrated healthcare company with a developing research and clinical trials divisions announces it has entered into a letter of intent with Crescita Capital LLC ("Crescita"...
VANCOUVER, BC / ACCESSWIRE / May 9, 2023 / EMPOWER CLINICS INC (CSE:EPW)(OTC PINK:EPWCF) (" Empower " or the " Company ") an integrated healthcare company with a developing research and clinical trials divisions announces various corporate updates. RESEARCH AND CLINICAL TRIALS The Company an...
Addition Of a Fourth Principal Investigator Sets the Stage for Numerous Research Contracts at First SMO Site and Company Attends Annual ACRP Conference in Dallas Texas VANCOUVER, BC / ACCESSWIRE / May 3, 2023 / EMPOWER CLINICS INC (CSE:EPW)(OTC PINK:EPWCF) (" Empower " or the " Company ") an...
Addition Of Seasoned Principal Investigators At First SMO Site Dramatically Expands Access to Securing Multiple Research Projects Covering Numerous Specialties VANCOUVER, BC / ACCESSWIRE / April 25, 2023 / EMPOWER CLINICS INC (CSE:EPW)(PINK:EPWCF) (" Empower " or the " Company ") an integrat...
The launch of PulseIR will deliver a data-driven, digital IR marketing platform to enhance IR communications and investor engagement. VANCOUVER, BC / ACCESSWIRE / April 20, 2023 / EMPOWER CLINICS INC (CSE:EPW)(OTC PINK:EPWCF) ("Empower" or the "Company"), an integrated healthcare company - s...
News, Short Squeeze, Breakout and More Instantly...
BioHarvest Sciences Inc (CNVCF) is expected to report for quarter end 2023-12-31 QS Energy Inc (QSEP) is expected to report for Q4 2023 NKGen Biotech Inc. (NKGN) is expected to report for Q4 2023 Cal-Maine Foods Inc. (CALM) is expected to report for Q3 2024 Davide Campari (DVDCF) ...
Iochpe-Maxion S.A. ADR (IOCJY) is expected to report for quarter end 2023-12-31 The Alkaline Water Company Inc. (WTER) is expected to report for Q3 2024 Clover Leaf Capital Corp. (CLOE) is expected to report for Q4 2023 Silvergate Capital Corporation Class A (SICP) is expected to repo...
Caleres Inc. (CAL) is expected to report $0.86 for Q4 2024 B Communications Ltd (BCOMF) is expected to report for quarter end 2023-12-31 Dermata Therapeutics Inc. (DRMA) is expected to report for Q4 2023 Core & Main Inc. Class A (CNM) is expected to report $0.34 for Q4 2024 Wi...